NR3C1 and post-traumatic stress disorder: Our analysis indicates potential of targeting redox regulation (67), inflammation, and modulation of GR sensitivity as the therapeutic alternatives for managing metabolic abnormalities in PTSD, motivating further controlled experiments to validate the causal role of enhanced GC sensitivity in metabolic dysregulation and test its therapeutic potential for managing metabolic dysfunction in PTSD.